SAN2014 Meeting
30 January 2014 - 02 February 2014
It is our great pleasure to welcome you to the conference website of the 2014 Meeting of the Society of Applied Neurosciences (SAN), jointly organized with the National Initiative Brain and Cognition (NIHC). The conference will be held from January 30th to February 2nd, 2014 in the Royal Dutch Jaarbeurs in Utrecht (The Netherlands).
Confirmed keynote speakers include Niels Birbaumer, John Gruzelier, Pascal Fries, Katya Rubia and Thomas Schlaepfer. Further keynote and invited speakers will be announced later.
Royal Dutch Jaarbeurs, Utrecht, Netherlands
http://applied-neuroscience.org/index.php/san2014/home
Practical Applications of NMR in Industry Conference (PANIC)
03 February 2014 - 05 February 2014
Practical Applications of NMR in Industry Conference (PANIC) was initiated to provide an interactive forum for discussion of the latest developments in the use of NMR for practical applications to real problems faced by scientists in industry and research institutions. The emphasis is the practicality of the solution and “getting the job done”. The forum will provide a venue for presentation of practical applications, and workshops for discussion of real-world experiences relevant to current product development needs with an opportunity to share case studies to drive further development of NMR technology. Solution-state, solid-state, time-domain, and zero-field applications are all equally welcome at PANIC. The forum also will provide a venue for industrial, regulatory, government, and academic scientists to meet, network, and participate in exchanges of knowledge for mutual education in and advancement of the use of NMR techniques.
Hilton Charlotte University Place, Charlotte, NC, USA
http://www.panicnmr.com/
Bioinformatics for Big Data: How Applications of Big Data will Drive Research Forward
10 February 2014 - 12 February 2014
Moscone North Convention Center, San Francisco, CA, USA
http://www.triconference.com/
Parallel Trade
10 February 2014 - 11 February 2014
The event will cover the latest regulation in the industry and offer guidance on compliance and best practice. Using data to manage parallel trade; anti-counterfeiting and competition law; building best practice processes; effective supply chain management; and differing perspectives from throughout the supply chain are just a selection of topics which will be featured. Leading pharmaceutical companies, legislative bodies and wholesalers will be speaking about their challenges and practical solutions to minimise loss and drive business performance. The event represents an excellent means for knowledge sharing and learning about case studies across the industry.
Senior management personnel will be speaking about their successes and analysing recent cases. This event promises to be a high quality practical event with plenty of opportunity for debate and offers you step-by-step guidance on the complex issue of parallel trade.
Marriott Regents Park Hotel, London, UK
http://www.smi-online.co.uk/pharmaceuticals/uk/conference/parallel-trade
Advances and Progress in Drug Design
17 February 2014 - 18 February 2014
This exciting event will focus on new approaches and will offer attendees the chance to hear from leading industry experts on lead optimisation strategies, SBDD, FBDD and phenotypic screening.
SMi's annual conference on drug design in 2014 will provide attendees with a broad perspective on the industry and will focus on lead optimisation strategies, discussion of fragment based drug design, new approaches in structure based drug design and the role of water in drug design. This comprehensive event will bring together key industry experts to discuss, debate and share ideas and challenges facing the drug design arena.
Marriott Regents Park Hotel, London, UK
http://www.smi-online.co.uk/pharmaceuticals/uk/conference/drug-design
Physiologically-Relevant Cellular Models for Drug Discovery
19 February 2014 - 21 February 2014
Traditional drug screening relies on monolayer cell culture, which is not always predictive of natural physiological state, where the complex microenvironment consists of various cell types that interact in 3-dimensional structures. As the cost of drug development rises, there is increasing pressure for more predictive in vitro models for functional analysis and compound characterization. Cambridge Healthtech Institute’s Inaugural Physiologically-Relevant Cellular Models for Drug Discovery meeting will focus on the latest advances in 3-D cellular models, complex co-culture systems, and simple model organisms for functional analysis studies and compound screening/characterization.
Marriott San Diego La Jolla, La Jolla, CA, USA
http://www.healthtech.com/cellular-models/
2nd Orphan Drugs Research & Commercialization Conference
20 February 2014 - 21 February 2014
We invite you to the 2nd Orphan Drugs Research & Commercialization Conference, happening February 20-21, 2014 in San Diego, CA.
This meeting provides a forum for all stakeholders, from researchers, industry leaders, patient advocacy organizations, and regulatory experts to gather and share different perspectives on how to best guide the field forward. The program will include presentations on the latest scientific research, such as RNAi therapeutics and gene therapy; pricing and reimbursement challenges; clinical endpoints; and much more.
Sessions for this year's meeting include:
I. Emerging Therapeutics in Rare Diseases
II. Engaging with All Stakeholders
III. From the Clinic to the Markets
IV. Overcoming Post-Approval Challenges
Hyatt Regency Mission Bay, San Diego, CA, USA
http://www.gtcbio.com/conference/orphan-overview?utm_source=3rdparty&utm_medium=website&utm_content=odrc_overview&utm_campaign=odrc_posting
6th Ocular Diseases Drug Discovery Conference
20 February 2014 - 21 February 2014
The conference continues to offer presentations on novel and innovative therapeutics in ocular drug development and discovery. This forum allows for excellent networking, the exchange of ideas, and sharing of challenges; all with a united common goal of bringing new and innovative treatments to patients in the area of ophthalmology.
The conference features the following topics:
Session: Novel Targets, Developments and Technologies
Session: Novel Drug Delivery Methods to the Anterior and Posterior Segments
Session: Clinical Development Advances & Updates
Session: Safety Assessment and Regulatory Landscape in Ocular Drug Development
Session: Short Presentations
Panel Discussion: BD, Investments and Potential for Collaborations
Panel Discussion: Safety and Regulatory in Ocular Development
San Diego, CA, USA
http://www.gtcbio.com/component/conference/?file=home&cn=5th+Ocular+Diseases+&Drug_Development=&cid=23&utm_source=3rdparty&utm_medium=eventlisting&utm_campaign=ocular13
Cell & Gene Therapy Conference
20 February 2014 - 21 February 2014
Treatment of disease using cell and gene therapy is now a reality. With emerging technologies and new clinical trials being developed and launched at a growing rate, this meeting will discuss the evolving regulatory challenges and pre-clinical requirements, the development and applications of cell and gene therapy, immune responses, as well as business model and commercial milestones.
Hyatt Regency Mission Bay San Diego, CA, USA
http://www.gtcbio.com/conference/cell-and-gene-therapy-overview
Predictive Toxicology
24 February 2014 - 26 February 2014
As demonstrated by Vioxx and Exanta, failing to identify adverse effects of new drugs can be financially devestating. With budget cuts hitting the R&D field hard, ensuring candidate compounds are safe is even more important to reduce late stage attrition and product withdrawals.
But how do we cost-effectively develop and implement these in silico, in vitro and in vivo methods as early in drug discovery and development as possible? How do we demonstrate the validation of these methods?
tbc London, UK
http://www.predictivetoxicology.com/
Quality by Design
24 February 2014 - 25 February 2014
Today more than ever regulatory guidance is increasingly focussing on the process robustness and product quality. The pharma world is also changing at an increasingly quickening pace. QbD philosophies must be quickly adapted for the development of any innovative products in order to ensure overall integrity.
QbD as a systamatic approach enables products and process understanding and control, based on comprehensive science and quality risk management schemes. By understanding a product i.e. by formulation and processes in great detail, systamatic approaches can be developed from an early stage to design quality into a product.
Marriott Regents Park Hotel, London, UK
http://www.smi-online.co.uk/pharmaceuticals/uk/conference/quality-by-design
9th Annual Biomarkers Congress 2014
25 February 2014 - 26 February 2014
The Biomarkers Congress will cover the latest advances in biomarker discovery and verification, including mass cytometry, selected reaction monitoring and chemical genetics. Our expert speakers will also discuss efforts to increase biomarker sensitivity and specificity through genomic analysis, informatics approaches and better sample management. In the Companion Diagnostics stream, presentations will cover emerging technologies, optimisation of existing platforms and strategies to improve strategic partnerships.
Manchester United’s Old Trafford, Manchester, UK
http://www.biomarkers-congress.com/
Smartlab Exchange
25 February 2014 - 26 February 2014
Companies that are operating in a highly regulated laboratory environment or have heavy R&D requirements are facing tough challenges. Our research shows that the on-going economic recession and an increase in global competition means that whether you are developing new drugs, engines, food, beverages or computer chips, companies are under constant pressure to increase productivity whilst cutting costs.
Through real-life case studies, round-table discussions and practical workshops the 2014 SmartLab Exchange will help you find ways to get your products to market both fast and cost effectively by learning how to do more with less.
Leonardo Royal Hotel Munich Munich, Germany
http://www.smartlabexchange.com/
Smartlab Exchange
25 February 2014 - 26 February 2014
Companies that are operating in a highly regulated laboratory environment or have heavy R&D requirements are facing tough challenges. Our research shows that the on-going economic recession and an increase in global competition means that whether you are developing new drugs, engines, food, beverages or computer chips, companies are under constant pressure to increase productivity whilst cutting costs.
Through real-life case studies, round-table discussions and practical workshops the 2014 SmartLab Exchange will help you find ways to get your products to market both fast and cost effectively by learning how to do more with less.
Munich, Germany
http://www.smartlabexchange.com/Default.aspx